ImmunoPrecise Antibodies Ltd.
IPA
$0.3918
-$0.0082-2.05%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.27M | -20.17M | -19.81M | -10.30M | -11.61M |
| Total Depreciation and Amortization | 4.12M | 4.09M | 4.21M | 3.44M | 3.74M |
| Total Amortization of Deferred Charges | 67.70K | 54.50K | 42.10K | 1.11M | 1.10M |
| Total Other Non-Cash Items | 10.07M | 10.16M | 10.93M | 2.73M | 2.69M |
| Change in Net Operating Assets | 588.90K | 2.08M | 1.76M | 446.10K | -616.70K |
| Cash from Operations | -5.42M | -3.79M | -2.87M | -2.57M | -4.71M |
| Capital Expenditure | -948.00K | -1.12M | -1.03M | -541.00K | -845.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -109.40K | -96.10K | -96.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.20K | -77.80K | -14.10K | -25.90K | 68.20K |
| Cash from Investing | -1.02M | -1.20M | -1.15M | -663.10K | -873.00K |
| Total Debt Issued | 4.06M | 2.60M | -- | -- | -- |
| Total Debt Repaid | -1.43M | -1.33M | -1.34M | -1.42M | -1.48M |
| Issuance of Common Stock | 3.87M | 2.85M | 2.36M | 936.00K | 98.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.77M | 3.02M | 749.70K | -359.20K | -1.02M |
| Foreign Exchange rate Adjustments | -164.20K | -112.50K | -298.30K | -203.20K | -102.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.83M | -2.08M | -3.57M | -3.80M | -6.70M |
